Sir, Vitiligo is a depigmentary dermatosis in which destruction or loss of function of epidermal melanocytes occurs. [1] In Egypt, reported prevalence is 1.22% in overall population. [2] Neuropeptide Y (NPY) is produced either by sympathetic postganglionic nerve fibers or by activated macrophages. It stimulates melanocyte dendricity and regulates cell substrate adhesion, cell motility, and configuration. [3] It regulates catecholamine release [4] which was claimed to participate in the development of vitiligo. [5] The NPY gene contains four exons and is located on chromosome 7p15.1. [6] Single-nucleotide polymorphisms are genetic changes of one nucleotide and these changes could have functional implications. [7] The present study aimed to detect the association of NPY gene 399T/C polymorphism and vitiligo to explore if it increased disease risk or influenced clinical presentation in Egyptian patients.
Forty patients with vitiligo were selected and 40 healthy, age and gender-matched unrelated participants were enrolled as a control group. Control participants had no past or family history of vitiligo. A written consent form approved by local ethical research committee was obtained from every participant before study initiation.
Assessment of disease activity was done according to vitiligo disease activity score. [8] Assessment of disease severity was done by vitiligo area severity index score. [9] Patients with dermatological diseases other than vitiligo, with systemic, neurological, and/or autoimmune diseases or malignancy were excluded from the study.
Detection of NPY gene polymorphism was done by restriction fragment length polymorphism-polymerase chain reaction.
Clinical data of selected cases are summarized in Table 1. CC genotype and C allele were significantly associated with cases compared with controls. They increased vitiligo risk by 3.75 and 7 folds, respectively Figure 1a and b]. This was in agreement with Laddha et al. [1] T/C genotype was also significantly associated with cases. It increased vitiligo risk by 4.6 folds [ Figure 1a ]. This conflicted with Laddha et al. [1] Therefore, NPY gene polymorphism can be considered as a risk factor for vitiligo in Egyptian population.
CORRESPONDENCE
The NPY promoter region -399T/C polymorphism (T/C) is associated with the initiation of transcription and can change NPY transcription activity. [10] When the -399 locus contains the C nucleotide, plasma NPY levels are higher, [11] leading to increased catecholamine production.
Catecholamines contribute to melanocyte damage by free radical release or immune-mediated cytotoxicity. They stimulate the release of heat shock proteins by melanocytes and activate antigen-presenting cells such as dendritic cells and Langerhans cells. [4] In the current work, a significant association was found between T/C genotype and vitiligo lesions on extremities [ Figure 1c ]. This was not reported before and needs further investigation to be clarified.
The present work revealed lack of association between genotypes and disease activity. This was against the previous report of Laddha et al. [1] This controversy can be explained by different clinical criteria and ethnic backgrounds of selected populations. Therefore, based on the current finding, NPY antagonists may be used in future for vitiligo treatment. However, as vitiligo is a complex disease with multiple genes and immunological and environmental factors, single genetic study is not enough and studying other genes, gene-gene, and gene-environment interactions are needed.
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There are no conflicts of interest. Sir, Acute urticaria (AU) is a spontaneous mast-cell-driven cutaneous disease accompanied by release of histamine and other cytokines from active mast cells, with occurrence of wheals and/or angioedema and other systemic symptoms of <6 weeks duration. Bacterial infection was considered as one of the causative factors in AU. Procalcitonin (PCT) and interleukin-6 (IL-6) are important biomarkers in the diagnosis or prognosis of bacterial diseases. [1, 2] Our previous study has demonstrated that PCT and IL-6 are critical inflammation markers in the evaluation of bacteria-induced dermatosis. [3] In AU, there are evidences that laryngeal angioedema, acute intestinal, and stomach swelling are medical emergencies requiring prompt assessment and a period of symptomatic therapy. It has always been a challenge to ascertain the pathogenesis during the early disease onset, and plenty of causative factors including the potential allergic exposure, recent infection, history of concurrent medications, and ingestion of foods can induce AU. Data concerned on multiple inflammatory biomarkers in AU are limited. Thereby, we facilely performed combinatorial assessments of serum reactants and immunoglobulin E (IgE) to explore the potential etiology in AU patients with systemic symptoms.
All patients were diagnosed as AU following the EAACI/ GA 2 LEN/EDF/WAO guideline. [4] After obtaining informed consent, 42 adults and 23 children were enrolled to meet at least two or more of the following clinical presentations (generalized lesions, fever [>38°C], laryngeal angioedema, chest tightness, and abdominal pain) in our study from June to September, 2015. Patients received systemic therapies including anti-histamine, glucocorticoid, and/or antibiotic when necessary for 5-7 days. Data were presented as median (25-75% percentiles). Differences between two variables were analyzed by Mann-Whitney U-test. P < 0.05 was considered significant. Table 1 , in both adult and child groups, there were significant elevations of serum D-dimer, PCT, IL-6, C-reactive protein (CRP), and white blood cell count (WBC) levels in the early stage group, with the median value of at least 140% (WBC) and up to about 20-fold change (CRP) of their maximum laboratory reference values. The values of these markers decreased remarkably after treatment. Furthermore, there were significant differences of these biomarkers between fever group and nonfever group during the early stage. These results indicate that D-dimer, PCT, IL-6, CRP, and WBC can be used as crucial biomarkers to monitor the disease severity and activity of AU with systemic symptoms. Whereas, IgE and anti-streptolysin O levels did not differ before and after the treatment as well as between fever and nonfever group, indicating that IgE-mediated allergy and streptococcal infection are less likely to cause the urticaria lesion in this study. Normally, traditional markers of CRP and WBC are not specific for indication of bacterial infections. PCT below 0.1 ng/mL signifies the endpoint of bacterial infection that determines the discontinuation of antibiotic therapy. [5] Consequently, PCT levels help guide the antibiotic administration in our work. Sustained low
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